Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol

NCT00395148 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT00395148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00395148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol
Lead sponsor
Bayside Health
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2006
Completion date
March 31, 2008
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, heart disease